Takeda Pharmaceutical has a robust drug discovery pipeline to meet future clinical demand. Check out the upside and downside ...

SANYA, China — Rio Takeda of Japan shot a 3-under 69 on Saturday to hold a two-shot lead after three rounds of the LPGA’s Blue Bay tournament on China’s southern island of Hainan. Takeda was on ...

These patients may experience a high treatment burden, and severe symptoms can impact their quality of life,” said Andy Plump, M.D., Ph.D., President of R&D at Takeda. “We are deeply committed to ...

SANYA, China (AP) — Rio Takeda of Japan shot a 3-under 69 on Saturday to hold a two-shot lead after three rounds of the LPGA's Blue Bay tournament on China's southern island of Hainan.

In previous years, Takeda Pharmaceutical Co. would draw attention to Rare Disease Day on the last day of February by doing the usual things that drug companies do: host podcasts and panel ...

SANYA, China — Rio Takeda shot a blistering 8-under 64 on Sunday to win the LPGA’s Blue Bay tournament by six shots ahead of Minjee Lee of Australia, the second LPGA title for the young Japanese. The ...

Protagonist Therapeutics (NASDAQ:PTGX) and Takeda (NYSE:TAK) said on Monday that its late-stage study of rusfertide for the ...

SANYA, China (AP) — Rio Takeda shot a blistering 8-under 64 on Sunday to win the LPGA's Blue Bay tournament by six shots ahead of Minjee Lee of Australia, the second LPGA title for the young ...

SANYA, China — Rio Takeda shot a blistering 8-under 64 on Sunday to win the LPGA’s Blue Bay tournament by six shots ahead of Minjee Lee of Australia, the second LPGA title for the young ...

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers ...

Also Read: Neurocrine Obtains Exclusive Rights For Depression Drug, Takeda Reacquires Japan Rights The study met its primary endpoint and all four key secondary endpoints. Rusfertide is a first-in ...